The Microfluidics Prototype market is expected to grow from an estimated USD 715.5 million in 2024 to USD 4128.5 million in 2033, at a CAGR of 21.50% ...

Increasing investments in biotechnology and genomics for the detection of chronic diseases is driving the RNA transcriptome profiling test marketRockville, MD, Jan. 20, 2025 (GLOBE NEWSWIRE) -- ...

The targeting of telomeres offers promise for new cancer therapies, which can be aimed at disrupting the mechanisms that ...

Objectives SLE is a multifaceted autoimmune disorder with a complex pathogenesis involving genetic, environmental and ...

The immunoturbidimetric kits industry in the United States is predicted to reach USD 727.9 million by 2033, increasing at a 6 ...